BSECompany Update4 Aug 2026 · 4 Aug 2026, 05:11 pm
Emkay Confluence 2026
Krishna Institute of Medical Sciences Ltd · 543308
✦ AI Summary
Krishna Institute of Medical Sciences Ltd has announced an analyst/institutional investor meeting, Emkay Confluence 2026, scheduled for August 12, 2026, in Mumbai, India. The meeting is subject to change due to exigencies, and no unpublished price-sensitive information will be shared.
Analysis Scores
Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk5/10
Liquidity Impact8/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Krishna Institute of Medical Sciences Ltd - 543308 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Attachments (1)
📄pdf
Download →
821f7aae-26a2-4944-9b4a-de1ecebdc076.pdf
View document text
04th August, 2026
To, To,
The Secretary, The Secretary,
Bombay Stock Exchange Ltd (BSE) National Stock Exchange (NSE)
Phiroze Jheejheebhoy Towers, Exchange Plaza, 5th Floor
Dalal Street, Plot No.C/1, 'G' Block
Mumbai - 400 001. Bandra - Kurla Complex
Scrip Code - 543308 Mumbai - 400 051.
ISIN: INE967H01025 Symbol - KIMS
ISIN: INE967H01025
Dear Sir/Madam,
Sub: Disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure
Requirements) Regulations, 2015 - Intimation of Schedule of Analyst/ Institutional Investor
Meeting.
Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations,
2015, the details of the proposed schedule of the Analyst/ Institutional Investor Meeting is as follows:
Date of Event Venue Type of Meeting
Meeting
August 12, Emkay Confluence 2026 Mumbai, Group Meeting
2026 India
The above schedule is subject to change due to exigencies, if any.
No Unpublished Price Sensitive Information will be shared during the meeting.
This is for your information and records.
Thanking you,
Yours truly
For Krishna Institute of Medical Sciences Limited
Nagajayanthi J.R
Company Secretary & Compliance Officer